SkinHealth Systems Inc. (SKIN)
Nasdaq · Consumer Defensive · Household & Personal Products
$0.60−4.76%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $78.1M
- Forward P/E
- 3.2
- 52-week range
- $0.551 – $1.76
- 52-week change
- −61.82%
- EPS (trailing)
- −$0.22
- Next earnings
- Nov 5, 2026
Fiscal year to Dec 2025
- Revenue
- $301M (−10.02%)
- Net income
- −$9.5M
- Operating margin
- −6.9%
- Diluted EPS
- −$0.16
- Free cash flow
- $37.2M
From the company’s annual report on SEC EDGAR.
About SkinHealth Systems Inc.
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health.
Headquarters: Long Beach, United States · 613 employees · skinhealthsystems.com